Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Siena
S
S
Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy.
Villa
S
S
Bonadonna
G
G
Bregni
M
M
Gianni
A M
AM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology* / Q000379:methods; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D037102:Lectins / Q000627:therapeutic use*; D008212:Lymphocyte Depletion; D037121:Plant Lectins; D012276:Ricin / Q000627:therapeutic use*; D030262:Soybean Proteins; D013025:Glycine max; D013601:T-Lymphocytes / Q000276:immunology*; D010835:Phytohemagglutinins
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D037102:Lectins; D037121:Plant Lectins; D012276:Ricin; D030262:Soybean Proteins; C028824:soybean lectin; D010835:Phytohemagglutinins